Hydrochloric Acid

Hydrochloric Acid

SCHEMBL709785

C=CCP(CC=C)CC=C.Cl

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15569338 1.00 TSHR (0.31) TSHRALDH1A1
Hydrochloric Acid SCHEMBL15569340 1.00 TSHR (0.31) TSHRALDH1A1
SCHEMBL29587 0.96 TSHR (0.33) TSHRALDH1A1
Charcoal, Activated SCHEMBL7745778 0.92 TSHR (0.31) TSHRALDH1A1
Bromide SCHEMBL1653733 0.92 TSHR (0.31) TSHRALDH1A1
SCHEMBL569476 0.92 TSHR (0.31) TSHRALDH1A1
SCHEMBL28401032 0.92 TSHR (0.31) TSHRALDH1A1
SCHEMBL9413747 0.92 TSHR (0.31) TSHRALDH1A1
Water SCHEMBL4565708 0.92 TSHR (0.31) TSHRALDH1A1
Hydrogen Sulfide SCHEMBL28434446 0.92 TSHR (0.31) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728176-B2 Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2010-06-01 US claimed
US-20070098616-A1 Process for producing phosponium borate compound, novel phosphonium borate compound, and method of using the same HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2007-05-03 US claimed
EP-1688424-A1 PROCESS FOR PRODUCING PHOSPHONIUM BORATE COMPOUND, NOVEL PHOSPHONIUM BORATE COMPOUND, AND METHOD OF USING THE SAME HOKKO CHEMICAL INDUSTRY CO. LTD. (JP) 2006-08-09 EP claimed
EP-0481406-B1 Process for the metathesis of partially fluorinated hydrocarbons HOECHST AG (DE) 1996-01-03 EP claimed
EP-0483722-B1 Process for polymerization of partly fluorinated hydrocarbons containing a triple bond HOECHST AG (DE) 1995-01-11 EP claimed
US-5146017-A Tungsten complex catalyst HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-08 US claimed
CN-108982403-B Integrated system and method for online monitoring of chemical concentration in ionic liquid 雪佛龙美国公司 2021-12-28 CN disclosed
CN-108014660-B Integrated system for continuous injection of small amounts of immiscible liquids 雪佛龙美国公司 2021-05-18 CN disclosed
CN-108473880-B Regeneration of acidic ionic liquid without adding hydrogenation catalyst 雪佛龙美国公司 2021-04-13 CN disclosed
CN-109642165-B Integrated coalescing system for separating liquid hydrocarbons from dispersed ionic liquid 雪佛龙美国公司 2020-11-27 CN disclosed
CN-110891678-A Integrated reactor system for ionic liquid catalyzed hydrocarbon conversion 雪佛龙美国公司 2020-03-17 CN disclosed
US-10173194-B2 Systems for ionic liquid catalyzed alkylation based on a modular reactor CHEVRON U.S.A. INC. (US) 2019-01-08 US disclosed
US-9796642-B2 Pneumatically agitated ionic liquid alkylation using vaporization to remove reaction heat CHEVRON U.S.A. INC. (US) 2017-10-24 US disclosed
EP-1688424-A1 PROCESS FOR PRODUCING PHOSPHONIUM BORATE COMPOUND, NOVEL PHOSPHONIUM BORATE COMPOUND, AND METHOD OF USING THE SAME HOKKO CHEMICAL INDUSTRY CO. LTD. (JP) 2006-08-09 EP disclosed
US-6881478-B2 Polyketone fiber and process for producing the same ASAHI KASEI KABUSHIKI KAISHA (JP) 2005-04-19 US disclosed
US-20050031864-A1 Polyketone fiber and process for producing the same ASAHI KASEI KABUSHIKI KAISHA 2005-02-10 US disclosed
US-6818728-B2 HIGH STRENGTH; ELASTICITY; VISCOSITY; FATIGUQ RESISTANCE; PROCESSABILITY; HEAT RESISTANCE; DIMENSIONAL STABILITY; FOR REINFORCED COMPOSITES FOR TIRES, CORDS, BELTS, HOSES, OR BUILDING MATERIALS ASAHI KASEI KABUSHIKI KAISHA (JP) 2004-11-16 US disclosed
EP-1371759-A1 POLYKETONE FIBER AND PROCESS FOR PRODUCING THE SAME Asahi Kasei Kabushiki Kaisha (JP) 2003-12-17 EP disclosed
US-20030026981-A1 Polyketone fiber and process for producing the same ASAHI KASEI KABUSHIKI KAISHA 2003-02-06 US disclosed
US-5146017-A Tungsten complex catalyst HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10173194-B2 Systems for ionic liquid catalyzed alkylation based on a modular reactor INTS6, ALKBH3, INMT TSHR 1782/4885ALDH1A1 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.